---
share: "true"
BOX:
  - ê°•ì˜ë¡
í•™ê¸°:
  - "08"
ê³¼ëª©:
  - ë‚´ê³¼í•™1
íŒ€í‹°ì¹­: ë‚¨ë‚´
ì°¨ì‹œ: 3ì£¼ì°¨
ì§„í–‰ë¥ : 
tags:
  - 08ì¤‘ê°„
ì§„í–‰ë„: 40%
---

# Treatment of Primary Immune-mediated disease

 

# Principles

- **(1) ìê°€ë©´ì—­ì´ ì¼ì–´ë‚˜ì§€ ì•Šë„ë¡**, **(2) ë©´ì—­ ì–µì œ ì•½ë¬¼ë¡œ ì¸í•œ ë¶€ì‘ìš©ì„ ìµœì†Œí™”**í•˜ë„ë¡
  í•˜ëŠ” ê²ƒì´ ì¹˜ë£Œì˜ ì›ì¹™.
- ì•½ë¬¼ ë¶€ì‘ìš©ì´ ê°ìˆ˜ë˜ì–´ì•¼ í•œë‹¤.
- ê°€ëŠ¥í•œ ì²œì²œíˆ ì¤„ì—¬ì•¼ í•œë‹¤.
- ì²˜ìŒ ì•½ì´ íš¨ê³¼ê°€ ì—†ìœ¼ë©´ ë‹¤ë¥¸ ì•½ë¬¼ë¡œì˜ ë³€ê²½ì„ ê³ ë ¤í•œë‹¤.
- ì•½ë¬¼ íš¨ê³¼ì™€ ë¶€ì‘ìš©ì„ ë‘˜ ë‹¤ ì˜ ëª¨ë‹ˆí„°ë§í•œë‹¤. ê°œê°œì¸ì— ë”°ë¼ 

# Overview

- **Glucocorticoid**ì— ì†í•˜ëŠ” `predisone`ê³¼,
- ë¶€ì†(adjunctive) ë©´ì—­ì–µì œì œë“¤ : `Azathioprine`, `Chlorambucil`, `Cyclosporine`, `Vincristine`, `hIVIG`, `Mycophenolate mofetil` (MMF), `Leflunomide`
![[Pasted image 20241015220803.png|600]]

| Drug             | Dose (dog)                                                    |                              |
| ---------------- | ------------------------------------------------------------- | ---------------------------- |
| **Prednisolone** | 2-4 mg/kg/day                                                 |                              |
| **Azathioprine** | 2 mg/kg/day initially,<br>â†’ ê²©ì¼ ë³µìš©ìœ¼ë¡œ ì ì°¨ ê°ì†Œ                     | nucleotide<br>í•©ì„± ë°©í•´          |
| **Chlorambucil** | 0.1-0.2 mg/kg PO q24h initially,<br>â†’ ê²©ì¼ ë³µìš©ìœ¼ë¡œ ì ì°¨ ê°ì†Œ           | ì„¸í¬ë…ì„±/<br>ê³ ì–‘ì´                 |
| **Cyclosporine** | 5-10 mg/kg PO q12-24h,<br>ketoconazole ë³‘ìš© ì‹œ 1.25-5 mg/kg q12h | ì„¸í¬ë…ì„±/<br>ê³ ì–‘ì´                 |
| **Vincristine**  | 0.02 mg/kg IV as a single dose (ITP)                          | í•­ì•”ì œ                          |
| **hIVIG**        | 0.25-1.5 g/kg as an IV infusion, over 6-12h                   |                              |
| **MMF**          | 10 mg/g PO q12h                                               | nucleotide<br>í•©ì„± ë°©í•´          |
| **Leflunomide**  | 2-4 mg/kg PO q24h                                             | nucleotide<br>í•©ì„± ë°©í•´/<br>IMPA |

# ì•½ë¬¼

## 1ï¸âƒ£ Glucocorticoids (PDS = [Solondo])

- Effective + Rapid acting + Inexpensive = ğŸ‘
![[Pasted image 20241016003601.png|800]]

- **PDS(prednisolone)** ì´ìš©ì´ 90% ì´ìƒ
- ê°€ëŠ¥í•˜ë©´ **ê²½êµ¬ íˆ¬ì—¬**ê°€ ì´ìƒì , <u>ì£¼ì‚¬ì œë¡œëŠ” dexamethasone</u> ê°€ëŠ¥
- ê¸°ì „ : cytosolic glucocorticoid receptorì— ë¶€ì°©í•˜ì—¬ â†’ í•µìœ¼ë¡œ ì´ë™ â†’ DNAì— ë¶€ì°©í•˜ì—¬ DNA ì „ì‚¬ë¥¼ ë°©í•´
- ì´ˆê¸° íš¨ê³¼ : **ì í˜ˆêµ¬ íƒì‹ ì‘ìš©ì˜ ë°©í•´** (rapid decrease in the phagocytic activity)
- ì¥ê¸° íš¨ê³¼ : **ì„¸í¬ì„± ë©´ì—­ì˜ ì–µì œ** (suppression of cell-mediated immunity)
	- ì„¸í¬ë§‰ì˜ ì•ˆì •í™” | phospholipase A2ì˜ ì–µì œ | cytokine(IL-1, IL-6) ë°©ì¶œ ê°ì†Œ | Fc receptor ë°œí˜„ ê°ì†Œ

>[!info] Prednisolone (> Prednisone)
>- **Intermediate-acting** | **alternate day** (ê²©ì¼ ë³µìš©) | **2-2.2 mg/kg/day PO(=ê²½êµ¬)**
>- Predisoneì´ ê°„ì—ì„œ ëŒ€ì‚¬ë˜ë©´ **prednisolone**. -soloneì˜ ìƒì²´ì´ìš©ë¥ ì´ í›¨ì”¬ ë†’ê³ , êµ­ë‚´ì—ëŠ” -solone ì œì œë§Œ ìˆìŒ.
>- ê³ ì–‘ì´ëŠ” ë” ë†’ì€ ì €í•­ì„±ì„ ê°€ì§.
>	- 2ë°° ìš©ëŸ‰ íˆ¬ì—¬ (2-4 mg/kg/day)
>	- 4 mg/week dexamethasone (í•œ ë²ˆì— ê¸¸ê²Œ but ì˜ ì“°ëŠ” ë°©ë²•ì€ ì•„ë‹˜)
>- Septic shock, ë¶€ì‹  ì§ˆë³‘, í˜¸í¡ê¸° ì§ˆí™˜, ê°„, ìœ„ì¥ê´€, ë©´ì—­ë§¤ê°œì§ˆë³‘, í”¼ë¶€ë³‘, í•­ì•”, ì—¼ì¦ ì™„í™”, ì†Œì–‘ê° ê°ì†Œ ë“± ë‹¤ì–‘í•œ íš¨ê³¼ê°€ ìˆìœ¼ë‚˜, <u>ê°ì—¼ì¼ ë•ŒëŠ” ê¶Œì¥ë˜ì§€ ì•ŠëŠ”ë‹¤</u>.

| ì¥ê¸° ë¶€ì‘ìš© (ì¿ ì‹± ì¦ìƒ ìœ ì‚¬)                                       |
| ------------------------------------------------------- |
| polydipsia/polyuria (ë‹¤ìŒ/ë‹¤ë‡¨)                             |
| panting (í—¥í—¥ê±°ë¦¼)<br>                                      |
| weakness (í—ˆì•½)                                           |
| dermatologic changes (í”¼ë¶€ ë³€í™”)                            |
| predisposition to infection (ê°ì—¼ì— ì·¨ì•½)                    |
| gastrointestinal hemorrhage (ìœ„ì¥ê´€ ì¶œí˜ˆ)                    |
| muscle atrophy (ê·¼ìœ¡ ìœ„ì¶•)                                  |
| **ëœ í”í•˜ê²ŒëŠ”..**                                            |
| insulin resistance (ì¸ìŠë¦° ì €í•­ì„±)                            |
| hyperglycemia (ê³ í˜ˆë‹¹ì¦)                                    |
| vacuolar hepatopathy (ê³µí¬ì„± ê°„ë³‘ì¦)                          |
| hypercoagulability (ê³¼ì‘ê³ ) : TEG(thromboelastography)ë¡œ ê²€ì‚¬ |
\* í˜ˆë‹¹ì„ ë†’ì´ê¸° ë•Œë¬¸ì— ë‹¹ë‡¨ í™˜ìì—ì„œ ì£¼ì˜
<br>
- ë¶€ì‘ìš© ìµœì†Œí™” + íš¨ê³¼ ê·¹ëŒ€í™”ë¥¼ ìœ„í•´
	- **ê³ ìš©ëŸ‰(ì •ëŸ‰)** ìœ¼ë¡œ ì‹œì‘í•˜ë˜ (high doses initially)
	- ì ì°¨ ì¤„ì—¬ì„œ ì§ˆë³‘ì„ í†µì œí•  ìˆ˜ ìˆëŠ” **ìµœì†Œ ìš©ëŸ‰ì— ë„ë‹¬** (lowest dose possible)
	- short-actingì´ ê¶Œì¥ë˜ë©°, alternative-day therapy (ê²©ì¼ íˆ¬ì•½)ì´ ì¢‹ë‹¤.
	- ë‹¨ê¸°ê°„ì— ê¸‰í•˜ê²Œ ì•½ì„ ì¤„ì´ë©´ ì¬ë°œ ìœ„í—˜ì´ ë†’ì•„ì§€ë¯€ë¡œ, ì²œì²œíˆ ì¤„ì´ë„ë¡ í•œë‹¤ (slowly tapered)
	  : í•œ ë‹¬ì— ê¸°ì¡´ ëŒ€ë¹„ 50% ì´ìƒ ì¤„ì´ì§€ ì•Šë„ë¡ í•œë‹¤. (ë³´í†µ 2ì£¼ì— 1ë²ˆ tapering)
- ê³ ì–‘ì´ì—ì„œëŠ” ë¶€ì‘ìš©ì´ ëœí•œ í¸.
- Steroid ì•½ë¬¼ì´ íš¨ê³¼ê°€ ì—†ì„ ê²½ìš° â†’ ë‹¤ë¥¸ ë©´ì—­ì–µì œì œë¥¼ ì‚¬ìš©. ì´ë•Œ ìŠ¤í…Œë¡œì´ë“œ ì•½ë¬¼ì„ í•œ ë²ˆì— ëŠìœ¼ë©´ ì•ˆ ë¨(ì²´ë‚´ í•©ì„±ëŸ‰ ì¤„ì–´ë“  ìƒíƒœ), ì ì°¨ ì¤„ì´ë˜ ë¹ ë¥´ê²Œ í•œë‹¤.

## 2ï¸âƒ£ Azathioprine = [IMURAN]

>[!info] Azathioprine
>- Thiopurineì˜ í•­ëŒ€ì‚¬ë¬¼ì§ˆ(antimetabolite), adenineì˜ í™© ìœ ë„ì²´(sulfur adenine)
>	- purineê³¼ ê²½ìŸì ìœ¼ë¡œ ì‘ìš©í•˜ì—¬ ì •ìƒì ì¸ DNA, RNA í•©ì„±ì„ ë°©í•´ â†’ ë©´ì—­ ì„¸í¬ì˜ í•©ì„±ì„ ì €í•´
>- azathioprineì´ í¡ìˆ˜ë˜ë©´ â†’ **6-MP**(mercaptopurine) â†’ ê°„ì—ì„œ ë§ì€ í•­ëŒ€ì‚¬ë¬¼ì§ˆì´ ìƒì„±ë¨.
>- **6-TGN**(thioguanine nucleotides) : ìµœì¢… cytotoxic metabolites
>- íŠ¹íˆ Të¦¼í”„êµ¬ë¥¼ ì–µì œí•˜ì—¬ ì„¸í¬ì„± ë©´ì—­ì„ ì–µì œí•¨.
>- ê°„ ê¸°ëŠ¥ì´ ë–¨ì–´ì§€ë©´ ë©´ì—­ ì–µì œ íš¨ê³¼ë„ ê°ì†Œí•  ìˆ˜ ìˆìŒ.
>![[Pasted image 20241016005522.png|450]]

- ê°€ì¥ ì˜¤ë˜ëœ ì•½ë¬¼
- 2ì„  ì•½ë¬¼ë¡œ ìì£¼ ì„ íƒë¨. (IMHA, ITP, IMPA, SLE, inflammatory bowel disease ë“±)
- 2 mg/kg PO q24h ì—ì„œ ì‹œì‘ â†’ ê²©ì¼(~3ì¼ì— 1ë²ˆ)ê¹Œì§€ tapering.
- PDSì™€ ê°™ì€ ìŠ¤í…Œë¡œì´ë“œ ì•½ë¬¼ê³¼ ë§ì´ ë³‘ìš©ë¨. (steroidë¥¼ ëŠê¸° ìœ„í•´)
  : PDSë¥¼ 2-4ê°œì›”ì— ê±¸ì³ ì¤„ì´ê³ , azathioprineì€ ìœ ì§€ â†’ ê´œì°®ìœ¼ë©´, azathioprineë„ tapering (2ì¼ â†’ 3ì¼ì— 1ë²ˆ..)

- ìŠ¤í…Œë¡œì´ë“œëŠ” ë¶€ì‘ìš©ì´ í”í•˜ì§€ë§Œ ì‰½ê²Œ í•´ì†Œë˜ëŠ” ë°˜ë©´, azathioprineì—ì„œëŠ” ë¶€ì‘ìš©ì´ í”í•˜ì§€ ì•Šì§€ë§Œ ìƒê¸°ë©´ ì‹¬ê°í•œ í¸.

| ë¶€ì‘ìš©                              |                                                                        |
| -------------------------------- | ---------------------------------------------------------------------- |
| bone marrow suppression (ê³¨ìˆ˜ ì–µì••)  | â†’ neutropenia, thrombocytopenia, (anemia)<br>   (ì•½ì„ ëŠìœ¼ë©´ 2ì£¼ ë‚´ íšŒë³µ)       |
| gastrointestinal upset (ìœ„ì¥ê´€ ë¶€ì‘ìš©) |                                                                        |
| pancreatitis (ì·Œì¥ì—¼)               |                                                                        |
| hepatotoxicity (ê°„ë…ì„±)             | â†’ 15%ì˜ ê°œì—ì„œ ALT(alanine aminotransferase) ì¦ê°€<br>   (German sheperds ë¯¼ê°) |
- ì´ˆë°˜ì—ëŠ” ë§¤ 1-2ì£¼ë§ˆë‹¤ ë¶€ì‘ìš© ëª¨ë‹ˆí„°ë§ í•„ìš”
- ê³ ì–‘ì´ì—ì„œëŠ” ì‚¬ìš©í•˜ì§€ ì•ŠìŒ. (ì‹¬ê°í•œ neutropenia, thrombocytopenia ë°œìƒ / ê°œì™€ ë‹¬ë¦¬ íšŒë³µ ì–´ë ¤ì›€.)
## 3ï¸âƒ£ Chlorambucil = [Leukeran]
- ë¦¼í”„ ê³„ì—´ ì¢…ì–‘ì—ì„œ ë” í”í•˜ê²Œ ì‚¬ìš©ë˜ëŠ” ì•½ë¬¼.
- ëŒ€ì‚¬ì²´ì¸ phenyl acetic acid mustardê°€ ì¹˜ë£Œ íš¨ê³¼ë¥¼ ë‚˜íƒ€ëƒ„.
- ì„¸í¬ë…ì„± ì•½ë¬¼ì´ ì•ˆë  ë•Œ ëŒ€ì²´ ì•½ë¬¼. <u>ê³ ì–‘ì´ì—ì„œëŠ” azathioprine ëŒ€ì‹ </u> ë§ì´ ì‚¬ìš©í•¨.
	- ê³ ì–‘ì´ì—ì„œ gastrointestinal lymphoma(ì†Œí™”ê¸° ë¦¼í”„ì¢…)ì—ë„ í”íˆ ì‚¬ìš©.
	-  ë©´ì—­ë§¤ê°œì„± ì¥ì—¼ê³¼ êµ¬ë¶„ì´ ì–´ë µì§€ë§Œ, ëª…í™•í•œ ì§„ë‹¨ ì „ì—ë„ ì ìš© ê°€ëŠ¥.
- ê°œì™€ ê³ ì–‘ì´ì—ì„œ ë‘˜ ë‹¤ 0.1-0.2 mg/kg PO q24h ìœ¼ë¡œ ì‹œì‘.
- ë¶€ì‘ìš© : bone marrow suppression (ê³¨ìˆ˜ ì–µì••), gastrointestinal upset (ìœ„ì¥ê´€ ë¶€ì‘ìš©), predisposition to infection(ê°ì—¼ ì·¨ì•½) (\*ëª¨ë“  ë©´ì—­ì–µì œì œì˜ ê¸°ë³¸ ë¶€ì‘ìš©)
## 4ï¸âƒ£ Cyclosporine = [Atopica], [Neoral]
- ê³°íŒ¡ì´ì—ì„œ ì¶”ì¶œëœ cyclic polypeptide


## 5ï¸âƒ£ Mycophenolate mofetil

## 6ï¸âƒ£ Splenectomy

## 7ï¸âƒ£ Human intravenous Immunoglobulin

## 8ï¸âƒ£ Pentoxifylline

## 9ï¸âƒ£ Vincristine